Aflac Incorporated (NYSE:AFL) Stock Position Cut by Prudential PLC

Prudential PLC cut its stake in Aflac Incorporated (NYSE:AFL - Free Report) by 5.2% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 119,065 shares of the financial services provider's stock after selling 6,483 shares during the quarter. Prudential PLC's holdings in Aflac were worth $12,316,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in AFL. Private Trust Co. NA grew its position in shares of Aflac by 1.3% during the fourth quarter. Private Trust Co. NA now owns 7,643 shares of the financial services provider's stock worth $791,000 after buying an additional 99 shares in the last quarter. Phillips Wealth Planners LLC raised its position in Aflac by 1.5% in the 4th quarter. Phillips Wealth Planners LLC now owns 6,553 shares of the financial services provider's stock valued at $662,000 after purchasing an additional 100 shares during the last quarter. Raleigh Capital Management Inc. boosted its stake in Aflac by 23.2% during the 4th quarter. Raleigh Capital Management Inc. now owns 531 shares of the financial services provider's stock worth $55,000 after purchasing an additional 100 shares during the period. TKG Advisors LLC increased its stake in Aflac by 0.5% in the fourth quarter. TKG Advisors LLC now owns 21,255 shares of the financial services provider's stock valued at $2,230,000 after purchasing an additional 103 shares during the period. Finally, Robertson Stephens Wealth Management LLC raised its holdings in shares of Aflac by 1.6% in the fourth quarter. Robertson Stephens Wealth Management LLC now owns 6,960 shares of the financial services provider's stock valued at $720,000 after buying an additional 107 shares during the last quarter. 67.44% of the stock is currently owned by institutional investors.

Remove Ads

Insiders Place Their Bets

In related news, Director Joseph L. Moskowitz sold 1,000 shares of the stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $107.63, for a total value of $107,630.00. Following the sale, the director now owns 25,393 shares of the company's stock, valued at $2,733,048.59. This trade represents a 3.79 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Charles D. Lake II sold 29,802 shares of the business's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the transaction, the director now directly owns 49,962 shares of the company's stock, valued at $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by corporate insiders.

Aflac Stock Down 1.3 %

AFL traded down $1.32 on Thursday, reaching $103.98. The company's stock had a trading volume of 903,198 shares, compared to its average volume of 2,146,970. The business's 50 day moving average is $106.38 and its 200 day moving average is $107.48. Aflac Incorporated has a 1 year low of $79.31 and a 1 year high of $115.50. The stock has a market cap of $56.75 billion, a price-to-earnings ratio of 10.88, a price-to-earnings-growth ratio of 3.24 and a beta of 0.81. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08.

Aflac (NYSE:AFL - Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, research analysts forecast that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have commented on AFL. Piper Sandler upped their price objective on Aflac from $118.00 to $124.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Wells Fargo & Company dropped their price objective on shares of Aflac from $104.00 to $102.00 and set an "equal weight" rating on the stock in a research note on Wednesday, February 19th. Barclays lowered their target price on shares of Aflac from $98.00 to $95.00 and set an "underweight" rating on the stock in a report on Friday, February 7th. Morgan Stanley reduced their price objective on shares of Aflac from $105.00 to $100.00 and set an "equal weight" rating for the company in a research report on Thursday. Finally, StockNews.com raised Aflac from a "sell" rating to a "hold" rating in a research note on Friday, February 14th. Two equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $103.93.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.